Assertio Holdings Inc
ASRT0.713USD
+0.001+0.07%
交易中 （美东）报价延迟15分钟
68.29M总市值
亏损市盈率 TTM
关于 Assertio Holdings Inc 公司
Assertio Holdings, Inc. 是一家为患者提供差异化产品的商业制药公司。该公司通过收购或授权已获批准的产品建立了自己的商业组合。其全面的商业能力包括通过销售团队和非个人推广模式进行营销、通过付款人签约进入市场以及贸易和分销。该公司的主要营销产品包括 ROLVEDONTM（eflapegrastim-xnst）皮下注射剂、INDOCIN（吲哚美辛）栓剂、INDOCIN（吲哚美辛）口服混悬液、Sympazan（氯巴占）口服膜、Otrexup（甲氨蝶呤）皮下注射剂、SPRIX（酮咯酸氨丁三醇）鼻喷雾剂、CAMBIA（双氯芬酸钾口服溶液）和 Zipsor（双氯芬酸钾）液体胶囊。 INDOCIN（吲哚美辛）栓剂和 INDOCIN（吲哚美辛）口服混悬液产品是非甾体抗炎药 (NSAID)。
公司简介
公司代码ASRT
公司名称Assertio Holdings Inc
上市日期Feb 12, 1997
CEOMr. Brendan P. O'Grady
员工数量58
证券类型Ordinary Share
年结日Feb 12
公司地址100 S. Saunders Road
城市LAKE FOREST
上市交易所NASDAQ Capital Market Consolidated
国家United States of America
邮编60045
电话12244197106
网址https://www.assertiotx.com/
公司代码ASRT
上市日期Feb 12, 1997
CEOMr. Brendan P. O'Grady
公司高管
名称
名称/职务
职务
持股
持股变动
Mr. Ajay Patel
Mr. Ajay Patel
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
196.85K
+12.05%
Mr. Paul Schwichtenberg
Mr. Paul Schwichtenberg
Executive Vice President, Chief Transformation Officer
Executive Vice President, Chief Transformation Officer
167.52K
+14.47%
Mr. Sam Schlessinger
Mr. Sam Schlessinger
Executive Vice President, General Counsel
Executive Vice President, General Counsel
156.13K
+17.33%
Mr. Brendan P. O'Grady
Mr. Brendan P. O'Grady
Chief Executive Officer, Director
Chief Executive Officer, Director
128.96K
+1001.61%
Mr. David Matthew Stark
Mr. David Matthew Stark
Independent Director
Independent Director
107.50K
+100.00%
Mr. William T. Mckee
Mr. William T. Mckee
Independent Director
Independent Director
97.28K
+123.48%
Mr. Mark L Reisenauer
Mr. Mark L Reisenauer
Independent Director
Independent Director
53.75K
--
Ms. Heather L. Mason
Ms. Heather L. Mason
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Sigurd C. (Sig) Kirk
Mr. Sigurd C. (Sig) Kirk
Independent Director
Independent Director
--
--
Mr. Sravan K. Emany
Mr. Sravan K. Emany
Independent Director
Independent Director
--
--
查看更多
名称
名称/职务
职务
持股
持股变动
Mr. Ajay Patel
Mr. Ajay Patel
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
196.85K
+12.05%
Mr. Paul Schwichtenberg
Mr. Paul Schwichtenberg
Executive Vice President, Chief Transformation Officer
Executive Vice President, Chief Transformation Officer
167.52K
+14.47%
Mr. Sam Schlessinger
Mr. Sam Schlessinger
Executive Vice President, General Counsel
Executive Vice President, General Counsel
156.13K
+17.33%
Mr. Brendan P. O'Grady
Mr. Brendan P. O'Grady
Chief Executive Officer, Director
Chief Executive Officer, Director
128.96K
+1001.61%
Mr. David Matthew Stark
Mr. David Matthew Stark
Independent Director
Independent Director
107.50K
+100.00%
Mr. William T. Mckee
Mr. William T. Mckee
Independent Director
Independent Director
97.28K
+123.48%
收入明细
单位: USD更新时间: 7月6日 周日
单位: USD更新时间: 7月6日 周日
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
业务USD
名称
营收
占比
ROLVEDON
13.12M
49.54%
INDOCIN products
5.54M
20.93%
other
3.56M
13.44%
Sympazan
2.18M
8.23%
SPRIX Nasal Spray
1.59M
6.00%
Royalties and milestone revenue
494.00K
1.86%
地区USD
名称
营收
占比
United States
26.49M
100.00%
业务
地区
业务USD
名称
营收
占比
ROLVEDON
13.12M
49.54%
INDOCIN products
5.54M
20.93%
other
3.56M
13.44%
Sympazan
2.18M
8.23%
SPRIX Nasal Spray
1.59M
6.00%
Royalties and milestone revenue
494.00K
1.86%
股东统计
更新时间: 5月16日 周五
更新时间: 5月16日 周五
持股股东
股东类型
持股股东
持股股东
占比
Nantahala Capital Management, LLC
8.81%
The Vanguard Group, Inc.
4.58%
Renaissance Technologies LLC
2.82%
BlackRock Institutional Trust Company, N.A.
1.45%
Two Sigma Investments, LP
1.28%
Other
81.06%
持股股东
持股股东
占比
Nantahala Capital Management, LLC
8.81%
The Vanguard Group, Inc.
4.58%
Renaissance Technologies LLC
2.82%
BlackRock Institutional Trust Company, N.A.
1.45%
Two Sigma Investments, LP
1.28%
Other
81.06%
股东类型
持股股东
占比
Hedge Fund
13.93%
Investment Advisor
9.29%
Investment Advisor/Hedge Fund
3.63%
Individual Investor
2.63%
Research Firm
0.15%
Other
70.37%
机构持股
更新时间: 7月1日 周二
更新时间: 7月1日 周二
报告期
机构数
持股数
持股占比
持股变动
2025Q2
311
28.39M
29.65%
-30.82M
2025Q1
337
28.16M
29.40%
-32.55M
2024Q4
339
31.00M
32.47%
-30.41M
2024Q3
330
33.06M
34.86%
-33.72M
2024Q2
326
40.98M
43.17%
-33.17M
2024Q1
316
48.96M
52.78%
-20.37M
2023Q4
308
49.49M
53.68%
-10.26M
2023Q3
295
49.25M
53.86%
+8.83M
2023Q2
258
36.71M
65.25%
+1.46M
2023Q1
203
27.95M
50.57%
+2.57M
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
Nantahala Capital Management, LLC
8.44M
8.81%
+291.43K
+3.58%
Mar 31, 2025
The Vanguard Group, Inc.
4.38M
4.58%
--
--
Mar 31, 2025
Renaissance Technologies LLC
2.70M
2.82%
-289.05K
-9.66%
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
1.39M
1.45%
-13.17K
-0.94%
Mar 31, 2025
Two Sigma Investments, LP
1.23M
1.28%
-401.09K
-24.66%
Mar 31, 2025
Geode Capital Management, L.L.C.
1.11M
1.16%
+11.78K
+1.08%
Mar 31, 2025
Millennium Management LLC
784.58K
0.82%
-316.70K
-28.76%
Mar 31, 2025
Polen Capital Management, LLC
424.06K
0.44%
-227.56K
-34.92%
Nov 30, 2024
AQR Capital Management, LLC
636.77K
0.66%
-265.80K
-29.45%
Mar 31, 2025
Peisert (Daniel A)
607.46K
0.63%
--
--
Mar 13, 2025
查看更多
持股ETF
更新时间: 8月2日 周六
更新时间: 8月2日 周六
机构名称
占比
Invesco RAFI US 1500 Small-Mid ETF
0.01%
Franklin US Small Cap Multifactor Index ETF
0%
ALPS Barron's 400 ETF
0%
iShares Russell 2000 Value ETF
0%
iShares Russell 2000 ETF
0%
Avantis Responsible US Equity ETF
0%
Global X Russell 2000 ETF
0%
Royce Quant Small-Cap Quality Value ETF
0%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
0%
Avantis US Small Cap Equity ETF
0%
查看更多
Invesco RAFI US 1500 Small-Mid ETF
占比0.01%
Franklin US Small Cap Multifactor Index ETF
占比0%
ALPS Barron's 400 ETF
占比0%
iShares Russell 2000 Value ETF
占比0%
iShares Russell 2000 ETF
占比0%
Avantis Responsible US Equity ETF
占比0%
Global X Russell 2000 ETF
占比0%
Royce Quant Small-Cap Quality Value ETF
占比0%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
占比0%
Avantis US Small Cap Equity ETF
占比0%
分红派息
近5年累计派现
0.00
美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据
拆合股
公告日期
类型
比率
May 17, 2021
Merger
4<1
May 17, 2021
Merger
4<1
May 17, 2021
Merger
4<1
May 17, 2021
Merger
4<1
公告日期
类型
比率
May 17, 2021
Merger
4<1
May 17, 2021
Merger
4<1
May 17, 2021
Merger
4<1
May 17, 2021
Merger
4<1
